Canada markets close in 2 hours 56 minutes

Canntab Therapeutics Limited (CTABF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.59850.0000 (0.00%)
As of 10:31AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close0.5985
Open0.5985
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.5985 - 0.5985
52 Week Range0.4798 - 0.8940
Volume70
Avg. Volume1,440
Market Cap22.337M
Beta (5Y Monthly)1.21
PE Ratio (TTM)N/A
EPS (TTM)-0.0920
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateMar. 08, 2016
1y Target EstN/A
  • CNW Group

    CANNTAB OFFICIALLY LAUNCHES ITS ONLINE E-COMMERCE PLATFORM

    Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce the official launch of its online e-commerce platform and web site at www.Canntab.ca.

  • GlobeNewswire

    Levitee Labs Partners with Canntab Therapeutics to Provide Alternatives to Opioids

    The agreement is anticipated to contribute to correcting the opioid crisis in Canada and serve as a foundation for both companies to potentially expand into new verticals in the futureLevitee Labs and Canntab Therapeutics have executed a services agreement resulting in Levitee Labs informing patients about the Canntab portfolio of therapeuticsLevitee Labs will offer the entire Canntab product lineup throughout all its clinics and pharmacies in Western Canada VANCOUVER, British Columbia, Jan. 10,

  • CNW Group

    CANNTAB DELIVERS 1st SHIPMENT TO THE ONTARIO CANNABIS STORE AND 2nd SHIPMENT TO AUSTRALIA

    Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to provide an update on its recent product deliveries for Ontario and Australia.